Zobrazeno 1 - 10 of 119 pro vyhledávání: '"Digkas, E."'
1
Akademický článek
Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer.
Autor: Ladjevardi CO; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, 751 85, Uppsala, Sweden., Skribek M; Thoracic Oncology Center, Theme Cancer, Karolinska University Hospital, 171 76, Stockholm, Sweden.; Department of Oncology-Pathology, Karolinska Institutet, 171 77, Stockholm, Sweden., Koliadi A; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, 751 85, Uppsala, Sweden., Rydén V; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, 751 85, Uppsala, Sweden., El-Naggar AI; Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden., Digkas E; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.; Department of Oncology, Mälarsjukhuset, 633 49, Eskilstuna, Sweden., Valachis A; Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. antonios.valachis@oru.se., Ullenhag GJ; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, 751 85, Uppsala, Sweden.
Publikováno v: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Nov 07; Vol. 74 (1), pp. 14. Date of Electronic Publication: 2024 Nov 07.
Zobrazit plný text záznamu
2
Akademický článek
Multiple immune-related adverse events secondary to checkpoint inhibitor therapy in patients with advanced cancer: association with treatment effectiveness.
Autor: Olsson Ladjevardi C; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, Uppsala, Sweden., Koliadi A; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, Uppsala, Sweden., Rydén V; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, Uppsala, Sweden., El-Naggar AI; Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden., Digkas E; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.; Department of Oncology, Mälarsjukhuset, Eskilstuna, Sweden., Valachis A; Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden., Ullenhag GJ; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, Uppsala, Sweden.
Publikováno v: Frontiers in oncology [Front Oncol] 2024 Jun 26; Vol. 14, pp. 1399171. Date of Electronic Publication: 2024 Jun 26 (Print Publication: 2024).
Zobrazit plný text záznamu
3
Akademický článek
The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta-analysis.
Autor: Rydén V; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, Uppsala, Sweden., El-Naggar AI; Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.; Department of Oncology, Örebro University Hospital, Örebro, Sweden., Koliadi A; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, Uppsala, Sweden., Ladjevardi CO; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, Uppsala, Sweden., Digkas E; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, Uppsala, Sweden.; Department of Oncology, Eskilstuna, Sweden., Valachis A; Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.; Department of Oncology, Örebro University Hospital, Örebro, Sweden., Ullenhag GJ; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, Uppsala, Sweden.
Publikováno v: Pigment cell & melanoma research [Pigment Cell Melanoma Res] 2024 May; Vol. 37 (3), pp. 352-362. Date of Electronic Publication: 2023 Dec 29.
Zobrazit plný text záznamu
4
Akademický článek
Incidence and risk factors of hypothyroidism after treatment for early breast cancer: a population-based cohort study.
Autor: Digkas E; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. Evangelos.Digkas@igp.uu.se.; Department of Oncology, Uppsala University Hospital, Uppsala, Sweden. Evangelos.Digkas@igp.uu.se., Smith DR; Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden., Wennstig AK; Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden.; Department of Oncology, Sundsvall Hospital, Sundsvall, Sweden., Matikas A; Department of Oncology/Pathology, Karolinska Institute, Stockholm, Sweden.; Breast Center, Karolinska Comprehensive Cancer Center and Karolinska University Hospital, Stockholm, Sweden., Tegnelius E; Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden., Valachis A; Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Feb; Vol. 204 (1), pp. 79-87. Date of Electronic Publication: 2023 Dec 07.
Zobrazit plný text záznamu
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Akademický článek
Predicting immune-related adverse events using a simplified frailty score in cancer patients treated with checkpoint inhibitors: A retrospective cohort study.
Autor: Olsson Ladjevardi C; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, Uppsala, Sweden., Koliadi A; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, Uppsala, Sweden., Rydén V; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, Uppsala, Sweden., Inan El-Naggar A; Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden., Digkas E; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.; Department of Oncology, Mälarsjukhuset, Eskilstuna, Sweden., Valachis A; Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden., Ullenhag GJ; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.; Department of Oncology, Uppsala University Hospital, Uppsala, Sweden.
Publikováno v: Cancer medicine [Cancer Med] 2023 Jun; Vol. 12 (12), pp. 13217-13224. Date of Electronic Publication: 2023 May 03.
Zobrazit plný text záznamu
8
Report
Randomized Versus Real-World Evidence on the Efficacy and Toxicity of Checkpoint Inhibitors in Cancer in Patients with Advanced Non-small Cell Lung Cancer or Melanoma: A Meta-analysis.
Autor: Digkas E; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Tabiim AJ; Department of Surgery, Korle-Bu Teaching Hospital, Accra, Ghana., Smith D; Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden., Valachis A; Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. Antonios.valachis@oru.se.
Publikováno v: Targeted oncology [Target Oncol] 2022 Sep; Vol. 17 (5), pp. 507-515. Date of Electronic Publication: 2022 Aug 01.
Zobrazit plný text záznamu
9
Akademický článek
Distribution of ABO and Rh blood groups in Greece: an update.
Autor: Lialiaris, T.1 lialiari@med.duth.gr, Digkas, E.1, Kareli, D.1, Pouliliou, S.1, Asimakopoulos, B.2, Pagonopoulou, O.2, Simopoulou, M.2
Publikováno v: International Journal of Immunogenetics. Feb2011, Vol. 38 Issue 1, p1-5. 5p. 1 Chart, 1 Map.
Zobrazit plný text záznamu
10
Akademický článek
Real-world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000-2014, focusing on patients aged >60 years.
Autor: Wahlin BE; Division of Haematology, Department of Medicine, Huddinge Karolinska Institutet Stockholm Sweden.; Haematology unit Karolinska University Hospital Stockholm Sweden., Övergaard N; Department of Immunology, Genetics and Pathology Uppsala University Uppsala Sweden., Peterson S; Regional Cancer Center South Lund Sweden., Digkas E; Department of Oncology Mälarsjukhuset Eskilstuna Sweden., Glimelius I; Department of Immunology, Genetics and Pathology Uppsala University Uppsala Sweden., Lagerlöf I; Department of Immunology, Genetics and Pathology Uppsala University Uppsala Sweden.; Department of Haematology University Hospital of Linköping Linköping Sweden., Johansson AS; Department of Oncology Umeå University Umeå Sweden., Palma M; Haematology unit Karolinska University Hospital Stockholm Sweden., Hansson L; Haematology unit Karolinska University Hospital Stockholm Sweden., Linderoth J; Department of Oncology Lund University Lund Sweden., Goldkuhl C; Department of Oncology Sahlgrenska University Hospital Gothenburg Sweden., Molin D; Department of Immunology, Genetics and Pathology Uppsala University Uppsala Sweden.
Publikováno v: EJHaem [EJHaem] 2021 May 06; Vol. 2 (3), pp. 400-412. Date of Electronic Publication: 2021 May 06 (Print Publication: 2021).
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje